{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:16:08Z","timestamp":1794028568334,"version":"4.8.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.biopha.2024.117792","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T12:06:06Z","timestamp":1735387566000},"page":"117792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Paraoxonase 1 ameliorates neurological symptoms and motor coordination impairment caused by cerebral ischemia-reperfusion injury"],"prefix":"10.1016","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4358-112X","authenticated-orcid":false,"given":"Naomi","family":"Asahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Ebisu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4539-7517","authenticated-orcid":false,"given":"Shinji","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.117792_bib1","first-page":"1","article-title":"Deaths: Leading causes for 2019","volume":"70","author":"Heron","year":"2021","journal-title":"Natl. Vital.-. Stat. Rep."},{"key":"10.1016\/j.biopha.2024.117792_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics-2022 update: a report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2024.117792_bib3","unstructured":"Stroke Association, Current, future and avoidable costs of stroke in the UK, 2017. \u3008https:\/\/www.stroke.org.uk\/sites\/default\/files\/costs_of_stroke_in_the_uk_summary_report_0.pdf\u3009 (Accessed 10 September 2024)."},{"key":"10.1016\/j.biopha.2024.117792_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001123","article-title":"American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee, heart disease and stroke statistics-2023 update: a report from the american heart association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2024.117792_bib5","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1161\/STROKEAHA.122.040073","article-title":"Projected global trends in ischemic stroke incidence, deaths and disability-adjusted life years from 2020 to 2030","volume":"54","author":"Pu","year":"2023","journal-title":"Stroke"},{"key":"10.1016\/j.biopha.2024.117792_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrcardio.2010.200","article-title":"Novel HDL-directed pharmacotherapeutic strategies","volume":"8","author":"deGoma","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2024.117792_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fcvm.2020.00039","article-title":"High density lipoproteins: metabolism, function, and therapeutic potential","volume":"7","author":"Jomard","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2024.117792_bib8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2013.02.003","article-title":"HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity","volume":"228","author":"Frias","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2024.117792_bib9","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/STROKEAHA.110.581512","article-title":"Protective effect of high-density lipoprotein-based therapy in a model of embolic stroke","volume":"41","author":"Lapergue","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.biopha.2024.117792_bib10","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"dal-OUTCOMES investigators, effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2024.117792_bib11","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","article-title":"ACCELERATE investigators, evacetrapib and cardiovascular outcomes in high-risk vascular disease","volume":"376","author":"Lincoff","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2024.117792_bib12","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/CIRCRESAHA.120.316526","article-title":"High-density lipoprotein carries markers that track with recovery from stroke","volume":"127","author":"Plubell","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2024.117792_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0009-2797(93)90022-Q","article-title":"Studies on human serum paraoxonase\/arylesterase","volume":"87","author":"La Du","year":"1993","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.biopha.2024.117792_bib14","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/nm1196-1186","article-title":"Structural and functional diversity of paraoxonases","volume":"2","author":"La Du","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2024.117792_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00041433-199604000-00004","article-title":"Paraoxonase: Biochemistry, genetics and relationship to plasma lipoproteins","volume":"7","author":"Mackness","year":"1996","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.biopha.2024.117792_bib16","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0090-9556(25)06732-7","article-title":"Comparison of purified human and rabbit serum paraoxonases","volume":"23","author":"Kuo","year":"1995","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.biopha.2024.117792_bib17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0090-9556(25)07065-5","article-title":"Purification of human serum paraoxonase\/arylesterase. Evidence for one esterase catalyzing both activities","volume":"19","author":"Gan","year":"1991","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.biopha.2024.117792_bib18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/28406","article-title":"Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis","volume":"394","author":"Shih","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.117792_bib19","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/hq0901.094247","article-title":"Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?","volume":"21","author":"Mackness","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2024.117792_bib20","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1161\/01.CIR.0000070954.00271.13","article-title":"Low paraoxonase activity predicts coronary events in the Caerphilly prospective study","volume":"107","author":"Mackness","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2024.117792_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2013.01.036","article-title":"A functional polymorphism of PON1 interferes with microRNA binding to increase the risk of ischemic stroke and carotid atherosclerosis","volume":"228","author":"Liu","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2024.117792_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1179\/1351000213Y.0000000071","article-title":"Paraoxonase 1 in neurological disorders","volume":"19","author":"Menini","year":"2014","journal-title":"Redox Rep."},{"key":"10.1016\/j.biopha.2024.117792_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0021-9150(91)90215-O","article-title":"Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus","volume":"86","author":"Mackness","year":"1991","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2024.117792_bib24","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1161\/01.ATV.15.11.1812","article-title":"Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins","volume":"15","author":"Abbott","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2024.117792_bib25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000045161","article-title":"The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia","volume":"80","author":"Paragh","year":"1998","journal-title":"Nephron"},{"key":"10.1016\/j.biopha.2024.117792_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1515\/CCLM.2008.011","article-title":"Lipid peroxidation in stroke patients","volume":"46","author":"Ferretti","year":"2008","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.biopha.2024.117792_bib27","first-page":"403","article-title":"Oxidized LDL and paraoxanase status in ischemic stroke patients","volume":"52","author":"Sarkar","year":"2008","journal-title":"Indian J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2024.117792_bib28","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0014-5793(91)80962-3","article-title":"Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein","volume":"286","author":"Mackness","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2024.117792_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0021-9150(93)90183-U","article-title":"Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase","volume":"104","author":"Mackness","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2024.117792_bib30","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1172\/JCI118359","article-title":"Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein","volume":"96","author":"Watson","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2024.117792_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3540001","article-title":"Hydrolysis of platelet-activating factor by human serum paraoxonase","volume":"354","author":"Rodrigo","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2024.117792_bib32","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.117792_bib33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/abbi.1996.0187","article-title":"Reaction of phosphatidylcholine hydroperoxide in human plasma: The role of peroxidase and lecithin:cholesterol acyltransferase","volume":"329","author":"Nagata","year":"1996","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.biopha.2024.117792_bib34","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0022-2275(20)32537-2","article-title":"Reduction of phosphatidylcholine hydroperoxide by apolipoprotein A-I: purification of the hydroperoxide-reducing proteins from human blood plasma","volume":"39","author":"Mashima","year":"1998","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2024.117792_bib35","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/00004647-200009000-00006","article-title":"Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice","volume":"20","author":"Li","year":"2000","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.biopha.2024.117792_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.14533\/jbm.13.21","article-title":"LipoSEARCH\u00ae; Analytical GP-HPLC method for lipoprotein profiling and its applications","volume":"13","author":"Toshima","year":"2013","journal-title":"J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2024.117792_bib37","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0022-2275(20)30123-1","article-title":"A new online dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC","volume":"43","author":"Usui","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2024.117792_bib38","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1373\/clinchem.2006.070094","article-title":"Component analysis of HPLC profiles of unique lipoprotein subclass cholesterols for detection of coronary artery disease","volume":"52","author":"Okazaki","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.biopha.2024.117792_bib39","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/01.ATV.0000155017.60171.88","article-title":"Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography","volume":"25","author":"Okazaki","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2024.117792_bib40","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in Ingenuity Pathway Analysis","volume":"30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biopha.2024.117792_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.700847","article-title":"Understanding the exchange of systemic HDL particles into the brain and vascular cells has diagnostic and therapeutic implications for neurodegenerative diseases","volume":"12","author":"Van Valkenburgh","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2024.117792_bib42","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0006-291X(03)00308-5","article-title":"NF-kappa B activation in endothelial cells treated with oxidized high-density lipoprotein","volume":"303","author":"Matsunaga","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2024.117792_bib43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.atherosclerosis.2011.11.031","article-title":"Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL","volume":"221","author":"Els\u00f8e","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2024.117792_bib44","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12872-015-0124-z","article-title":"Endothelial cell control of thrombosis","volume":"15","author":"Yau","year":"2015","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.biopha.2024.117792_bib45","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1161\/01.STR.0000021902.33129.69","article-title":"Inflammatory cell adhesion molecules in ischemic cerebrovascular disease","volume":"33","author":"Frijns","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.biopha.2024.117792_bib46","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1194\/jlr.R039479","article-title":"Regulation of signal transduction by HDL","volume":"54","author":"Mineo","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2024.117792_bib47","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1161\/ATVBAHA.115.305887","article-title":"High-density lipoproteins reduce endothelial-to-mesenchymal transition","volume":"35","author":"Spillmann","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2024.117792_bib48","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s12264-022-00859-0","article-title":"Neuronal death mechanisms and therapeutic strategy in ischemic stroke","volume":"38","author":"Mao","year":"2022","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.biopha.2024.117792_bib49","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3390\/biomedicines10030574","article-title":"Oxidative stress in ischemia\/reperfusion injuries following acute ischemic stroke","volume":"10","author":"Jurcau","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2024.117792_bib50","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1194\/jlr.M400511-JLR200","article-title":"Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities","volume":"46","author":"Draganov","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2024.117792_bib51","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1021\/bi052076j","article-title":"Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia","volume":"45","author":"Sauls","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2024.117792_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0275956","article-title":"Homocysteine thiolactone contributes to the prognostic value of fibrin clot structure\/function in coronary artery disease","volume":"17","author":"Sikora","year":"2022","journal-title":"PLOS ONE"},{"key":"10.1016\/j.biopha.2024.117792_bib53","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1172\/JCI118345","article-title":"Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures","volume":"96","author":"Van Lenten","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2024.117792_bib54","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.ATV.21.4.481","article-title":"HDL and the inflammatory response induced by LDL-derived oxidized phospholipids","volume":"21","author":"Navab","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2024.117792_bib55","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1172\/JCI119134","article-title":"Paraoxonase polymorphism Met\u2013Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes","volume":"99","author":"Garin","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2024.117792_bib56","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00210-003-0833-1","article-title":"Pharmacogenetics of paraoxonases: a brief review","volume":"369","author":"Draganov","year":"2004","journal-title":"Naunyn. Schmiede Arch. Pharmacol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224016792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224016792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:15:53Z","timestamp":1776726953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224016792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":56,"alternative-id":["S0753332224016792"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117792","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paraoxonase 1 ameliorates neurological symptoms and motor coordination impairment caused by cerebral ischemia-reperfusion injury","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117792"}}